Orchid Cellmark Inc. (NASDAQ:ORCH)
Industry: Healthcare

OFF LIST - 2360 consecutive market days: OFF LIST as of 01/22/2007 Through 11/14/2016

Orchid Cellmark Inc. operates as an international provider of identity DNA testing services for the forensic, immigration, and family relationships markets. It has laboratories in the United States and the United Kingdom; and offers its services to the police forces and other government entities. The company also provides non-DNA forensic laboratory services. Its forensic DNA testing is primarily used to confirm that a suspect committed a particular crime, to exonerate an innocent person, or to establish or maintain databases of individuals convicted of crimes; and family relationship DNA testing is used to establish whether two or more people are genetically related. The companys DNA testing is used by individuals and employers in security applications to establish or store a persons genetic profile for identification purposes in the event of an emergency or accident. It also provides DNA testing services for agricultural applications, primarily in selective trait breeding. The company was formerly known as Orchid Biosciences, Inc. and changed its name to Orchid Cellmark Inc. in June 2005. Orchid Cellmark Inc. was founded in 1995 and is headquartered in Princeton, New Jersey.

Current Quote*
Last: $Unk
Change: 0.000
Book: $2.300
Volume: Unk

As Of: 08/30 13:17 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol ORCH

  • No BuyIns.Net Alerts Available for ORCH

Graphs for ORCH


3 Month Graph


6 Month Graph


1 Year Graph